Project 1 Publications

Simpkins JW, Perez E, Wang X, Yang S, Wen Y, Singh M. The potential for estrogens in preventing Alzheimer’s disease and vascular dementia. Ther Adv Neurol Disord. 2009 Jan;2(1):31-49. doi: 10.1177/1756285608100427. PubMed PMID: 19890493; PubMed Central PMCID: PMC2771945.

Cunningham RL, Macheda T, Watts LT, Poteet E, Singh M, Roberts JL, Giuffrida A. Androgens exacerbate motor  asymmetry  in  male rats with unilateral 6-hydroxydopamine lesion. Horm Behav. 2011 Nov;60(5):617-24. doi: 10.1016/j.yhbeh.2011.08.012. PubMed PMID: 21907204; PubMed Central PMCID: PMC3210335.

O’Bryant SE, Johnson L, Reisch J, Edwards M, Hall J, Barber R, Devous MD Sr, Royall D, Singh M. Risk factors for  mild cognitive impairment among Mexican Americans. Alzheimers Dement. 2013 Nov;9(6):622-631.e1. doi: 10.1016/j.jalz.2012.12.007. PubMed PMID: 23643456; PubMed Central PMCID: PMC3737282.

Singh M, Simpkins JW, Simpkins JW, Bimonte-Nelson HA, Bimonte-Nelson HA, Brinton RD, Brinton RD. Window of  opportunity for  estrogen and progestin intervention in  brain aging and Alzheimer’s disease. Brain Res. 2013 Jun 13;1514:1-2. doi:10.1016/j.brainres.2013.04.044. PubMed PMID: 23726132; PubMed Central PMCID: PMC4076427.

Singh M, Su C. Progesterone and neuroprotection. Horm Behav. 2013 Feb;63(2):284-90. doi: 10.1016/j.yhbeh.2012.06.003. Review. PubMed PMID: 22732134; PubMed Central PMCID:PMC3467329.

Singh M, Su C. Progesterone, brain-derived neurotrophic factor  and neuroprotection. Neuroscience. 2013 Jun 3;239:84-91. doi:10.1016/j.neuroscience.2012.09.056.  Review. PubMed PMID:23036620; PubMed Central PMCID: PMC3582842.

Singh M, Su C. Progesterone-induced neuroprotection: factors  that may  predict therapeutic efficacy. Brain Res. 2013 Jun 13;1514:98-106. doi: 10.1016/j.brainres.2013.01.027. Review. PubMed PMID:23340161; PubMed Central PMCID: PMC3672388.

Cunningham RL, Singh M, O’Bryant SE, Hall JR, Barber RC. Oxidative stress, testosterone, and cognition among Caucasian and Mexican-American men  with and without Alzheimer’s disease. J Alzheimers Dis. 2014;40(3):563-73. doi: 10.3233/JAD-131994. PubMed PMID: 24496073; PubMed Central PMCID:PMC4219556.

Hall JR, Wiechmann AR, Cunningham RL, Johnson LA, Edwards M, Barber RC, Singh M, Winter S, O’Bryant SE; Texas Alzheimer’s Research and Care Consortium.. Total  testosterone and neuropsychiatric symptoms in  elderly men  with  Alzheimer’s disease. Alzheimers Res Ther. 2015 May 1;7(1):24. doi: 10.1186/s13195-015-0107-4. PubMed PMID: 25937840; PubMed Central PMCID: PMC4416299.

Holmes S, Singh M, Su C, Cunningham RL. Effects  of  Oxidative Stress and Testosterone on   Pro-Inflammatory Signaling in  a  Female Rat Dopaminergic Neuronal Cell  Line. Endocrinology. 2016 Jul;157(7):2824-35. doi: 10.1210/en.2015-1738. PubMed PMID:27167771; PubMed Central PMCID: PMC4929547.

Sun F, Nguyen T, Jin X, Huang R, Chen Z, Cunningham RL, Singh M, Su C. Pgrmc1/BDNF  Signaling Plays a  Critical Role in Mediating Glia-Neuron Cross Talk. Endocrinology. 2016 May;157(5):2067-79. doi: 10.1210/en.2015-1610. PubMed PMID:26990062; PubMed Central PMCID: PMC4870882.

This page was last modified on March 22, 2017